<DOC>
	<DOCNO>NCT02817542</DOCNO>
	<brief_summary>Background . Patients ST-Elevation Myocardial Infarction ( STEMI ) hyperglycemia admission high rate mortality ( 1 ) . The management hyperglycemic patient STEMI unclear . We evaluate whether thrombus aspiration ( TA ) primary percutaneous coronary intervention ( PCI ) may improve STEMI outcome hyperglycemic patient ( 2 ) . Research Design Methods . Consecutive 990 hyperglycemic patient first STEMI undergo quantitative coronary angiography study . Patients categorize two group , either treat thrombus aspiration v/s patient treat without thrombus aspiration . After discharge hospital , patient manage follow quarterly 12 month month event , outpatient , perform clinical evaluation , routine analysis cardiovascular evaluation . The cardiovascular endpoint collect cohort include cardiac mortality , all-cause mortality hospitalization coronary disease heart failure . Conclusions . We attend improve outcome hyperglycemic patient treat TA PCI , compare hyperglycemic patient treat PCI .</brief_summary>
	<brief_title>Trhombus Aspiration Hyperglycemic ST-elevation myocardiAl InfarcTIon</brief_title>
	<detailed_description>The data analyze study obtain hyperglycemic STEMI patient underwent primary PCI Department Cardiology Cardarelli Hospital Naples Italy June 1 , 2016 , December 1 , 2017 . This prospective study compare two therapeutic strategy : PCI plus thrombus aspiration ( TA ) versus PCI alone patient STEMI hyperglycemia . According recent statement American Heart Association , hyperglycemia define admission plasma glucose level &gt; 140 mg/dl . Inclusion criterion include : age 18 year great , presentation cardiac catheterization laboratory PCI set first STEMI , admission plasma glucose level &gt; 140 mg/dl . All STEMI patient refer cardiac catheterization laboratory within 12 h presentation . Patients leave ventricular ejection fraction le 25 % , previous myocardial infarction previous PCI or/and coronary by-pass grafting , receive fibrinolytic therapy exclude study . The following patient refer urgent invasive diagnostics intention perform PCI : symptom duration 12 hour less ST-segment elevation 0.1 mV great least 2 contiguous lead ( â‰¥0.2 mV V1-V3 ) presume new-onset left bundle-branch block . The investigation conform principle outline Declaration Helsinki use human tissue subject . The Institutional Review Board approve protocol . Outcomes The primary outcome THAITI study all-cause mortality , cardiovascular death , recurrent myocardial infarction , cardiogenic shock , class IV heart failure within 360 day . Other outcome include target vessel revascularisation , stent thrombosis , stroke , transient ischaemic attack within 360 day .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<criteria>age 18 year great , presentation cardiac catheterization laboratory PCI set first STEMI , admission plasma glucose level ( &gt; 140 mg/dl hyperglycemic Group ) . patient leave ventricular ejection fraction le 25 % , previous myocardial infarction previous PCI or/and coronary bypass grafting .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>